You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. New In Vitro Human Liver Toxicity Bioassay System

    SBC: Vivo Biosciences Inc            Topic: NIEHS

    DESCRIPTION (provided by applicant): The overall objective of this SBIR proposal is to develop and commercialize a human 3D or mini- liver bioassay system suitable for real-time analysis of metabolic functions and long-term drug toxicity profiles. At present, liver functions are mostly studied using HepG2 cell line and primary hepatocytes cultured onto collagen or polymer matrices. However, these ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  2. A novel physiologically realistic microfluidic in-vitro blood-brain barrier model

    SBC: CFD RESEARCH CORPORATION            Topic: NIGMS

    DESCRIPTION (provided by applicant): The overall objective of this study is to develop a novel in vitro microfluidic platform to test a drug or delivery vehicle's ability to permeate the Blood-Brain Barrier (BBB). In contrast to current in-vitro models, our proposed device, SIM-BBB, comprises of a microfluidic two-compartment chamber. The chamber is designed in such a way as to permit vis ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  3. Novel Cyclofructan Based Chiral Selectors for Pharmaceutical Purification

    SBC: AZYP, LLC            Topic: NIGMS

    DESCRIPTION (provided by applicant): The separation of enantiomers (i.e. chiral separations) is of great importance in the development of safe chiral pharmaceuticals and the study of chiral biological toxins and carcinogens. For pharmaceutical compounds that are chiral, usually one enantiomer (either the right or left-handed version) is the drug, while the other half causes side effects, differen ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  4. Development of the PathLock biasing caster system Phase 2

    SBC: ACCESSIBLE DESIGNS, INC.            Topic: NICHD

    DESCRIPTION (provided by applicant): The importance of reducing the incidence of secondary injuries related to manual wheelchair (MWC) propulsion is undisputed. Based on several research studies, approximately 50% of manual wheelchair users (MWU) report symptoms of repetitive strain injury (RSI) related to the demand on the upper extremity during propulsion and transferring tasks. A substantial e ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  5. GI-Safer Formulation of Indomethacin for use in Preterm Neonates

    SBC: PLx Opco Inc.            Topic: NICHD

    DESCRIPTION (provided by applicant): This application is for a SBIR Phase II grant. One of the major causes of morbidity and mortality of low birth weight neonates relates to injury, inflammation, perforation and obstruction of the lower GI tract, which can be manifest in the related diseases Necrotizing Enterocolitis (NEC) and Spontaneous Intestinal Perforation (SIP). These digestive diseases, wh ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  6. Continuous Monitoring of Advanced Reading Skills (CMARS)

    SBC: IMAGINATION STATION, INC.            Topic: NICHD

    DESCRIPTION (provided by applicant): In this fast-track application, we propose to develop a Computer Adaptive Test (CAT) to provide universal ongoing, continuous progress assessment data of critical reading skills to teachers of students in grades 4 to 8.The primary purpose of this assessment will be to facilitate a teacher's ability to provide differentiated instruction for all students in ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  7. Targeted Neural Plasticity for the Treatment of Tinnitus

    SBC: MICROTRANSPONDER, INC.            Topic: NIDCD

    DESCRIPTION (provided by applicant): This is a proposal to conduct a multi-center, double-blind, sham-controlled partial cross-over interventional study to test safety and efficacy of our novel tinnitus therapy. The tinnitus field generally accepts that elevated synchronous spontaneous activity in the auditory cortex may account for the tinnitus percept that arises following hearing loss. Followin ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  8. Delivery system development for a reservoir targeted Lyme disease vaccine

    SBC: FoodSource Lure Corporation            Topic: NIAID

    DESCRIPTION (provided by applicant): The incidence and geographic distribution of Lyme disease in the U.S. has increased steadily since its first description in 1977. Efforts to stem the spread of the disease through controlling the population of its tickvector and/or the mouse reservoirs of the disease have met with only limited success. The only approved human vaccine to protect against Lyme di ...

    STTR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  9. Optimization of Protein Therapeutics Formulations

    SBC: SOLUBLE THERAPEUTICS, INC            Topic: NIGMS

    DESCRIPTION (provided by applicant): This proposal involves the development of a high-throughput self-interaction chromatography (SIC) system that will be used by Soluble Therapeutics, LLC, to improve and accelerate the formulation discovery process for biopharmaceuticals (i.e. vaccines, monoclonal antibodies and other therapeutic proteins). Biopharmaceuticals are used to treat a variety of infect ...

    STTR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  10. IGF::OT::IGF OTHER FUNCTIONS: TOPIC 287, PHASE II NANOTECHNOLOGY SENSING PLATFORMS

    SBC: OMEGA OPTICS, INC.            Topic: NCI

    Label-free, highly sensitive early cancer detection sensors with required specificity are in great demand. In Phase 1, we experimentally confirmed feasibility of our proposed photonic crystal (PC) microarray with real data better than all reported sensing methods. These include absolute biomolecule mass sensitivity 8.8attograms (10A-18grams), surface mass sensitivity 0.8picogram (10A-12grams)/m ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government